Effects of lovastatin in diabetic patients treated with chlorpropamide

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Clinical pharmacology and therapy

• Publication date

  1990-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/clpt.1990.176PMID 2225707
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.

  2020cited by this paper
• Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus.

  1988cited by this paper
• Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

  1987cited by this paper
• Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.

  1987cited by this paper
• Lipoprotein metabolism in diabetes mellitus.

  1987cited by this paper
• Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study.

  1986cited by this paper
• Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.

  1986cited by this paper
• Simultaneous determination of tolbutamide and its hydroxy and carboxy metabolites in plasma and urine by high-performance liquid chromatography.

  1986cited by this paper
• Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus.

  1986cited by this paper
• Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics.

  1985cited by this paper
• Effect of sulfonylurea therapy on plasma lipids and high-density lipoprotein composition in non-insulin-dependent diabetes mellitus.

  1985cited by this paper
• Diabetes as an atherogenic factor.

  1984cited by this paper
• The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.

  1984cited by this paper
• Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

  1984cited by this paper
• Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus.

  1983cited by this paper
• Plasma lipids and diabetes mellitus in an adult community.

  1982cited by this paper
• Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase.

  1982cited by this paper
• Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

  1980cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• Determination of serum tolbutamide and chlorpropamide by high-performance liquid chromatography.

  1978cited by this paper
• THE EFFECT OF LARGE DOSES OF NICOTINIC ACID ON CIRCULATING LIPIDS AND CARBOHYDRATE TOLERANCE

  1959cited by this paper

• STATIN ADVERSE EFFECTS: MECHANISMS, DIAGNOSIS, PREVENTION AND MANAGEMENT

  2018cites this paper
• ПОБОЧНЫЕ ЭФФЕКТЫ СТАТИНОВ: МЕХАНИЗМЫ РАЗВИТИЯ, ДИАГНОСТИКА, ПРОФИЛАКТИКА И ЛЕЧЕНИЕ

  2018cites this paper
• Statin-Associated Diabetes Mellitus: Review and Clinical Guide

  2016cites this paper
• A pharmacokinetic evaluation of pravastatin in middle-aged and elderly volunteers

  2010cites this paper
• Drug Interactions of Clinical Importance with Antihyperglycaemic Agents

  2005cites this paper
• Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.

  2005cites this paper
• Lipids and Diabetes Mellitus: A Review of Therapeutic Options

  2002cites this paper
• Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statins.

  2001cites this paper
• Clinical Pharmacology of Sulfonylureas

  1996cites this paper
• Pharmacokinetic drug interactions. Part 1: Drugs A-C.

  1995cites this paper
• Antihyperglycaemic Agents

  1995cites this paper
• Effect of Treatment With a Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor on Fasting and Postprandial Plasma Lipoproteins and Cholesteryl Ester Transfer Activity in Patients with NIDDM

  1995cites this paper
• Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia.

  1995cites this paper
• Dyslipidemias in Patients With Diabetes Mellitus: Classification and Risks and Benefits of Therapy

  1995cites this paper
• A multinational study of the effects of low‐dose pravastatin in patients with non‐insulin‐dependent diabetes mellitus and hypercholesterolemia

  1994cites this paper
• Lovastatin Does Not Affect Oral Glucose Tolerance in Hypercholesterolemic Patients

  1993cites this paper
• Author index

  1990cites this paper